Lemonade (NYSE:LMND) Insider Maya Prosor Sells 198 Shares of Stock

Lemonade, Inc. (NYSE:LMND) insider Maya Prosor sold 198 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $72.74, for a total transaction of $14,402.52. Following the completion of the transaction, the insider owned 7,627 shares of the company’s stock, valued at approximately $554,787.98. The trade was a 2.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Lemonade Trading Up 4.0%

LMND traded up $3.05 during trading on Friday, hitting $79.85. 642,141 shares of the company’s stock traded hands, compared to its average volume of 2,420,989. The stock has a market capitalization of $5.97 billion, a price-to-earnings ratio of -33.47 and a beta of 2.13. The company’s 50 day simple moving average is $62.63 and its two-hundred day simple moving average is $51.14. Lemonade, Inc. has a 12-month low of $24.31 and a 12-month high of $83.77.

Lemonade (NYSE:LMND) last announced its quarterly earnings results on Wednesday, November 5th. The company reported ($0.51) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.72) by $0.21. Lemonade had a negative return on equity of 31.86% and a negative net margin of 26.39%.The firm had revenue of $194.50 million for the quarter, compared to the consensus estimate of $185.06 million. During the same period in the prior year, the company posted ($0.95) earnings per share. The company’s quarterly revenue was up 42.4% on a year-over-year basis. On average, equities analysts expect that Lemonade, Inc. will post -3.03 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. BMO Capital Markets boosted their price objective on shares of Lemonade from $23.00 to $42.00 and gave the company an “underperform” rating in a report on Monday, August 18th. Citizens Jmp lifted their target price on shares of Lemonade from $60.00 to $80.00 and gave the stock a “market outperform” rating in a research report on Monday, November 24th. Wall Street Zen upgraded shares of Lemonade from a “sell” rating to a “hold” rating in a research note on Saturday, August 9th. JMP Securities set a $80.00 price target on Lemonade in a research note on Monday, November 24th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of Lemonade in a report on Monday, November 24th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $58.57.

Institutional Trading of Lemonade

Hedge funds have recently bought and sold shares of the stock. Bayforest Capital Ltd bought a new position in shares of Lemonade in the third quarter worth about $25,000. SVB Wealth LLC bought a new stake in Lemonade during the 1st quarter worth approximately $26,000. Strategic Advocates LLC bought a new stake in Lemonade during the 3rd quarter worth approximately $33,000. NewEdge Advisors LLC purchased a new position in Lemonade during the first quarter valued at approximately $35,000. Finally, Estabrook Capital Management bought a new position in shares of Lemonade in the second quarter worth approximately $44,000. Institutional investors own 80.30% of the company’s stock.

About Lemonade

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.